Literature DB >> 9854101

Viral superinfection in previously unrecognized chronic carriers of hepatitis B virus with superimposed acute fulminant versus nonfulminant hepatitis.

C M Chu1, C T Yeh, Y F Liaw.   

Abstract

The role of viral superinfection in hepatitis B surface antigen carriers with superimposed fulminant (n = 60) versus nonfulminant (n = 90) acute hepatitis was studied. The frequency of hepatitis A virus (HAV) (0 versus 2.2%), HCV (18.3 versus 21.1%), HDV (15.0 versus 7.8%), and HEV (1.7 versus 4.4%) infection showed no significant difference, while simultaneous HCV and HDV infection was significantly more prevalent in the former (8.3 versus 0%). Only 3. 6% of fulminant cases and 3.3% of nonfulminant controls were HGV RNA positive.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854101      PMCID: PMC84220     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Fulminant hepatitis in asymptomatic hepatitis B surface antigen carriers in Greece.

Authors:  N C Tassopoulos; G J Papaevangelou; A Roumeliotou-Karayannis; A Smedile; R Engle; J R Ticehurst; S M Feinstone; R H Purcell
Journal:  J Med Virol       Date:  1986-12       Impact factor: 2.327

2.  Evaluation of commercial enzyme immunoassays for detection of hepatitis delta antigen and anti-hepatitis delta virus (HDV) and immunoglobulin M anti-HDV antibodies.

Authors:  A G Shattock; M C Morris
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

3.  Changes of serum HBV-DNA in relation to serum transaminase level during acute exacerbation in patients with chronic type B hepatitis.

Authors:  Y F Liaw; C C Pao; C M Chu
Journal:  Liver       Date:  1988-08

4.  Associated infection with non-A, non-B virus as possible cause of liver failure in Indian HBV carriers.

Authors:  B N Tandon; H Gupta; M Irshad; Y K Joshi; T C Chawla
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

5.  Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey.

Authors:  G Saracco; S Macagno; F Rosina; M Rizzetto
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

6.  Serodiagnosis of acute viral hepatitis.

Authors:  J H Hoofnagle
Journal:  Hepatology       Date:  1983 Mar-Apr       Impact factor: 17.425

7.  Virological markers and antibody responses in fulminant viral hepatitis.

Authors:  V Bal; S N Amin; S Rath; S A Kamat; A J Zuckerman; S N Marathe; R S Kamat
Journal:  J Med Virol       Date:  1987-09       Impact factor: 2.327

8.  Etiology of fulminant viral hepatitis in Greece.

Authors:  G Papaevangelou; N Tassopoulos; A Roumeliotou-Karayannis; C Richardson
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

9.  Fulminant B viral hepatitis: role of delta agent.

Authors:  S Govindarajan; K P Chin; A G Redeker; R L Peters
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

10.  Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.

Authors:  C M Chu; P Karayiannis; M J Fowler; J Monjardino; Y F Liaw; H C Thomas
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

View more
  2 in total

1.  Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China.

Authors:  Wei-Min Ke; Xue-Jun Li; Li-Na Yu; Jing Lai; Xiao-He Li; Zhi-Liang Gao; Pei-Jia Chen
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 6.772

Review 2.  Immune mediated liver failure.

Authors:  Xiaojing Wang; Qin Ning
Journal:  EXCLI J       Date:  2014-10-01       Impact factor: 4.068

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.